![UNODC World Drug Report 2024](/files/styles/card/public/2024-07/1a.png?h=8606d1af&itok=MnRRWnjp)
![UNODC World Drug Report 2024](/files/styles/card/public/2024-07/1a.png?h=8606d1af&itok=MnRRWnjp)
Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of...
Лечение от алкоголизма и других наркологических расстройств, как правило, предоставляется только отдельным лицам, часто вдали от своих семей. Лечение направлено на улучшение самочувствия и снижение вреда от употребления психоактивных...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
В журнале CIJ Informa рассматривается участие CIJ, принимающего отделения ISSUP в Мексике, в 71-й очередной сессии CICAD .
The Anti-Stigma Network has been launched!
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Фон
Опиоидная зависимость связана со значительным бременем для здоровья и общества, и лечение опиоидными агонистами (ОАТ) является высокоэффективным для улучшения множественных исходов у людей, получающих это лечение. Метадон и...
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Кокаин - это стимулирующий наркотик, вызывающий привыкание, который происходит из листьев растения коки, произрастающего в Южной Америке. Эффекты препарата включают повышенную бдительность, внимание и энергию, а также чувство эйфории и...
Рынки гексагидроканнабинола (HHC) и связанных с ним полусинтетических каннабиноидов (SSC) являются быстро развивающимися областями, информация о которых в настоящее время относительно ограничена.
Ситуация в Европе...
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past...
Substance misuse among young people is one of the most public concerns in global health. This study set out to explore treatment barriers among young people in Zimbabwe.
Data was collected through interviews with 30 participants
The...
It has been widely reported that youth alcohol consumption has decreased over recent years. What is the evidence to support this view? What are the implications for alcohol related health harm, promotion of safe drinking and health policy?
...This report presents the most recent and in-depth data on overdose and drug-induced deaths in Australia, covering the period 2002 to 2021. It is the most recent output in a series of annual publications on trends in drug overdose deaths...
The Alcohol Use and Mental Health Project ECHO is a no-cost virtual program for health care professionals who are looking for up-to-date and research-based information on working with people who use alcohol.
The program, which is only...
Поделитесь знаниями: Члены ISSUP могут размещать информацию в разделе "Обмен знаниями" - зарегистрируйтесь или станьте членом организации